Article

Spreading the love: Children's cancer center opens in Tanzania

Author(s):

In honor of World Cancer Day (which was just on Feb. 4), The Love, Hope, Strength Foundation (LHS) and supporters of children with cancer, including representatives from The Tanzanian Ministry of Health and The Union for International Cancer Control (UICC), dedicated two cancer wards on Feb. 8 at Muhimbili National Hospital, Tanzania's first cancer wards devoted to children. The wards feature 32 new beds and the words "Tumaini, Upendo, Ujasiri," which is Swahili for love, hope, strength. (See pictures of the new center.) The children's wards are up to international standards and are designed to ease some of the strain on the Ocean Road Cancer Institute, which sees more than 500 children per year. LHS, whose motto is "Saving lives once concert at a time," funded the venture through star-studded treks to the peaks of Mt. Kilamanjaro, Pikes Peak and Mt. Fuji. Some of the climbers included co-founder and cancer survivor Mike Peters, who is part of the Welsh band The Alarm, Chris Carraba of Dashboard Confessional and the Gin Blossoms' Robin Wilson. CURE reported on LHS's past fund raising effort "Peru Rocks," which was a 10-day music fest with one of the highlights being a concert at Machu Picchu. The $300,000 raised by that event benefited the National Institute of Neoplastic Diseases in Lima.Check out Mike Peters rocking out at Mt. Everest base camp:

You can see more videos at LHS's YouTube channel for videos documenting the hikes and high altitude concerts.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of doctor.
Image of man with black hair.
Picture of Dr. Pouneh Razavi
Richard Winneker gathers input from patients and researchers to shape MPN research, aiming to fund strategic projects for this population.
Dr. Curtiland Deville Jr. discusses the importance of crafting an individualized treatment plan for patients with prostate cancer.
Image of man.
Image of Crispino
Image of Dr. Reznick
Picture of Joy Anderson
Some patients with relapsed/refractory diffuse large B-cell lymphoma whose disease progressed after CAR-T cell therapy, responded to odronextamab.
Related Content